Steris (STE) EBIAT (2018 - 2026)

Steris has reported EBIAT for 8 years, with the latest figure at $194.3 million in Q4 2025.

• For the quarter ending Q4 2025, EBIAT rose 11.99% year-over-year to $194.3 million; the trailing twelve-month figure through Dec 2025 stood at $715.6 million (up 52.54% YoY), and the FY2025 full-year result was $616.1 million, up 62.88% from the prior year.
• EBIAT for Q4 2025 stood at $194.3 million, up from $191.9 million in the prior quarter.
• The five-year high for EBIAT was $194.3 million in Q4 2025, with the low at -$315.2 million in Q3 2022.
• Average EBIAT over 5 years is $100.2 million, with a median of $135.7 million recorded in 2023.
• Year-over-year, EBIAT plunged 551.55% in 2022 and jumped 15207.19% in 2025.
• Tracing STE's EBIAT over 5 years: stood at $143.1 million in 2021, then retreated by 13.82% to $123.3 million in 2022, then grew by 14.12% to $140.7 million in 2023, then rose by 23.27% to $173.5 million in 2024, then climbed by 11.99% to $194.3 million in 2025.
• The last three EBIAT figures came in at $194.3 million (Q4 2025), $191.9 million (Q3 2025), and $178.0 million (Q2 2025), per Business Quant data.

Peer Comparison